Researchers take advantage of MBL International’s recombinant IL-18 to activate varying cells like peripheral blood cells, macrophages, NK cells and T cells to identify targets.
Immune Checkpoint Mechanism of Action
Leinco Technologies offers both GOLD™ and PLATINUM™ In vivo functional grade antibodies to important checkpoint markers for use in checkpoint research.
Recombinant Proteins including Growth Factors & Cytokines
In order to provide the most biologically active proteins, many of Leinco Technologies’ proteins are expressed using mammalian host cells,
My Cites are Set on You!
ProSci-Inc’s RIP3/RIPK3 antibody (Cat. No. PSI-2283) is widely cited with as many as 171 citations on CiteAb and 165 citations on Bioz.
Validation of Neoantigen In Silico Prediction using QuickSwitch™ Kits
Research findings indicate that neoantigens have the potential to activate tumour-specific T-cell-mediated anti-tumour immune responses.
Chimeric Antigen Receptor (CAR) T Cell Therapy
Chimeric Antigen Receptor (CAR) T cell therapy is a revolutionary approach in the field of cancer immunotherapy.
Immune Checkpoints
ProSci offers reagents that can be used to study the actions of multiple immune checkpoint proteins such as CTLA-4, PD-1, & its ligands PD-L1 & PD-L2.
Overcoming the Donor Selection Challenges to Drive Success in Cell and Gene Therapy Development and Commercialisation
AllCells’ Pre-Characterised Donor Selection Program expedites screening, selecting & collecting from donors for downstream clinical manufacturing.
Therapeutic Targets of the NAD+ Biosynthesis Pathway
CycLex NAMPT Colorimetric Assay Kit detects nicotinamide phosphoribosyltransferase (NAMPT) activity in recombinant NAMPT or endogenous NAMPT immunoprecipitated from cell extract.
Histone deacetylase (HDAC): important consideration in regulating gene expression
Histone deacetylase (HDAC) plays a pivotal role in the regulation of gene expression through the modification of nucleosome structure.